1 1.

Slides:



Advertisements
Similar presentations
Memorial Sloan-Kettering Cancer Center
Advertisements

Is Radical Prostatectomy Adequate For High Risk Prostate Cancer?
NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
DIAGNOSI E STADIAZIONE DEL CARCINOMA PROSTATICO Maurizio Brausi Direttore Urologia Ausl Modena Chairman ESOU Director Prostate Cancer Unit.
Endometrial Cancer Surgical Staging (Role of Lymphadenectomy) Karl Podratz MD PhD FACS.
Mechanism of Action Combidex in MR Imaging Mukesh Harisinghani, MD Department of Radiology, Massachusetts General Hospital.
Prostate Cancer Radical Prostatectomy
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Radiotherapy in prostate cancer Dr.Mina Tajvidi Radiation oncologist.
PROSTATE CANCER EXPECTED MANAGEMENT & CURATIVE TREATMENT Dr. Abdullah A. Ghazi (R5) KSMC.
Clinical Utility of Combidex in Various Cancers
Steven Joniau Filip Ameye
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
M. Wirth Department of Urology, Technical University of Dresden Adjuvant or Salvage Radiotherapy after Radical Prostatectomy.
Treatment options for locally recurrent Prostate Cancer Giuseppe Simone Mediterranean School of Oncology Roma
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
RISK OF NON SIGNIFICANT PROSTATE CANCER IN PROSTATE CANCER PATIENTS DIAGNOSED BY AN EXTENDED PROSTATE NEEDLE BIOPSY PROCEDURE AND TREATED BY RADICAL PROSTATECTOMY.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
Neck Cancer Head and STATEMENTS ON January 28, 2006 Frankfurt am Main, Germany Surgery Management of Lymph Node Metastases.
How and when to use nomograms for counseling patients with prostate cancer ? By the BAU Working Group of Urology.
DISCUSSION AND CONCLUSION Alberto Briganti Urological Research Institute Vita Salute San Raffaele University Dept. of Urology, Milan, Italy.
Laparoscopic Radical Prostatectomy: Oncological and Functional Outcomes Following Fellowship Training. Introduction Radical Prostatectomy (RP) is a technically.
Robert Dreicer, M.D., M.S., FACP Chair Dept of Solid Tumor Oncology
Prof. Francesco Boccardo University and National Cancer Research Institute of Genoa, Italy Prof. Francesco Boccardo University and National Cancer Research.
Lymphadenectomy in the surgical treatment of prostate cancer - does it influence survival? Oliver Hakenberg Urologische Klinik und Poliklinik Universitätsklinikum.
What’s new in PCA... Steven Joniau University Hospitals Leuven, Belgium EAU Guidelines 2010 update.
Poster Title ABSTRACT #59 Cell cycle progression genes differentiate indolent from aggressive prostate cancer. Steven Stone 1 Jack Cuzick 2, Julia Reid.
MpMRI in Prostate cancer A Urologist’s Perspective Diagnosis Treatment Choice Surgical Planning Dr. Peter Heathcote, Adjunct Professor APCRC-Q QUT, Senior.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Combined Modality Treatment of Locally Advanced Prostate Cancer: Radiation Therapy (RT) with Concurrent Androgen Deprivation Therapy (ADT) Howard Sandler.
PATTERNS OF CARE OF PATIENTS WITH AN OCCULT LOCOREGIONAL RELAPSE ON CHOLINE PET/CT AFTER A PRIOR CURATIVE TREATMENT FOR LOCALIZED PROSTATE CANCER Choline.
Operative Management of Osteosarcoma Patients with Pulmonary Metastasis Jen Kramer, MD R2 Swedish Medical Center February 2011.
South West Public Health Observatory The changing casemix of prostate cancer patients and prostatectomies in the South West Sean McPhail.
Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.
LOCAL TREATMENT OF OLIGOMETASTATIC DISEASE IN PROSTATE CANCER: LYMPHADENECTOMY Alberto Briganti, MD, fEBU Department of Urology Chair, Prostate Cancer.
IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC.
Surgical Management of Prostate Cancer
HOW TO WRITE THE RESULTS SECTION
Disfunzione erettile dopo prostatectomia radicale
Volume 61, Issue 3, Pages (March 2012)
Conseguenze cliniche della sorveglianza attiva Aldo Massimo Bocciardi
Surgical Treatment in Locally Advanced Prostate Cancer
Bladder Cancer and Prostatic Cancer
1 LINFOADENECTOMIA Alessandro Volpe Università del Piemonte Orientale
J. Edson PontesM.D. Professor Urologic Oncology WSU/KCI
Radical Prostatectomy in pN+ Prostate Cancer
Management of Invasive Bladder Cancer
RELAZIONE TRA “STAGE MIGRATION” E
Current role of androgen deprivation after surgery or radiotherapy of high-risk PCa Morgan Roupret, MD, PhD Pitié Salpétrière Hospital University Paris.
MANAGEMENT OF SMALL RENAL TUMORS: Current Evidence
Laparoscopic Radical prostatectomy: Is it still a treament of choice?
Post Op Positive Seminal Vesicle Case 4: Prostate_4
N.N. Alexandrov National Cancer Centre
Dr Tak-Hing Bill WONG Consultant Urologist & Head
Prostate Cancer: Highlights from 2006
Volume 51, Issue 6, Pages (June 2007)
Apollo Gleneagles Hospitals,
Volume 67, Issue 2, Pages (February 2015)
Luis Martínez-Piñeiro  European Urology Supplements 
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Active Surveillance for Low Risk Prostate Cancer
Management of endometrial cancer found on routine hysterectomy for benign disease Prof Dr M Anıl Onan MAY ANTALYA.
1 1.
Volume 54, Issue 2, Pages (August 2008)
Management of Prostate Cancer: Global Strategies
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Surgery for high-risk prostate cancer: The results of first 80 cases
Presentation transcript:

1 1

Ospedale “San Giovanni Bosco” Quale chirurgia? Alessandro Giacobbe Ospedale “San Giovanni Bosco” S.C. Urologia Torino 2 2

Surgical Issues Staging accuracy Surgical Margins PLND Multimodal Approach problematiche

Surgical Issues Staging accuracy Surgical Margins PLND Multimodal Approach problematiche

Staging accuracy Gleason upgrading Extracapsular extension Nodal involvement

Staging accuracy Gleason upgrading Extracapsular extension Nodal involvement

1/3 pts

Staging accuracy Gleason upgrading Extracapsular extension Nodal involvement

Side specific ECE risk PSA 8, cT1c, bGS 7 40%cores 30% Grazie ai nomogrammi è possibile predirre

Staging accuracy Gleason upgrading Extracapsular extension Nodal involvement

LNI risk PSA 7, cT2, bGS 7 40%cores 12% IF EXTENDED PLND!!! Nomogramma memorial e il nomogramma di Briganti sono diversi perché si basano su linfadenectomia limitata ed estesa. Si utilizza ciò che si crede di dover fare

If performed it should be extended PLND! “CLINICAL N STAGING” “The gold standard for N-staging is operative lymphadenectomy, either by open or laparoscopic techniques” PLND limited to the obturator fossa misses about 50% of node metastases If performed it should be extended PLND!

Surgical Issues Staging accuracy Surgical Margins PLND Multimodal Approach

PSM rate >50% In questa casistica monocentrica basata su RRP Open, psm > 50%

SEER DATABASE: 2004-2010 more than 11000 patients SEER, open vs Rarp, in robotica psm è nettamente piu bassa SEER DATABASE: 2004-2010 more than 11000 patients 4400 pts (40%) High Risk PCa (D’Amico)

Surgical Issues Staging accuracy Surgical Margins PLND Multimodal Approach

The indication for RP assumes the absence of clinically detectable nodal involvement. Only limited evidence exists supporting RP of cN+ patients In a recent study, the outcomes of 50 patients with cN+ were compared with those of 252 patients with pN1, but cN0 at preoperative staging: cN+ was not a significant predictor of cancer-specific mortality (CSM) (p = 0.6) Moschini, M., et al. Eur Urol, 2015. 69: 193. Due to the limited evidence, local treatment of cN+ patients, in association with a multimodal approach, should be discussed with patients on an individual basis.

Surgical Issues Staging accuracy Surgical Margins PLND Multimodal Approach

Database nazionale ….registro tumori …livello di evidenza forte

Adjuvant RT or prophylactic whole-pelvis RT ? Gleason score >7 the only predictor of eBCR after RP and aRT in pT3N0 PCa Adjuvant RT or prophylactic whole-pelvis RT ? Should pT3a GS6 R0 with undetectebale Psa receive adj RT? Gs sul margine?